AI Is No Longer Experimental Innovation in Action, Impact at Scale
The life sciences industry needs a shot of adrenaline. THAT SHOT OF adrenaline for life sciences organizations is artificial intelligence (AI), which is increasingly being integrated into every aspect of the industry’s value chain, from drug manufacturing, patient engagement and diagnostics to imaging.
The Harvard Business Review Analytic Services Report, sponsored by LTIMindtree, is a research-driven, curated publication that explores some of the most pressing challenges and opportunities shaping the Life Sciences industry today.
The report delves into:
- Maximizing data-driven impact in manufacturing
- Exploring real-world examples of AI-powered personalized care
- Establishing trust in AI across the life sciences value chain






